Video game maker Activision scores big gains in 3Q

SANTA MONICA, Calif. (AP) — Video game maker Activision Blizzard Inc. scored points in the third quarter with a performance that topped analysts’ forecasts.

The results announced Wednesday encouraged management to predict more good times in the crucial holiday shopping season when the company is counting on video game aficionados to snap up the latest edition in its popular “Call of Duty” franchise.

Activision credited “Diablo III,” a role-playing game designed for personal computers, and its latest version of “World of Warcraft” for moving its latest quarter to a higher level.

The company earned $ 226 million, or 20 cents per share, for the three months ending in September. That represented a 53 percent increase from net income of $ 148 million, or 13 cents per share a year ago.

Excluding items unrelated to its ongoing business, Activision made 15 cents per share. The company beat the average estimate of 8 cents per share among analysts surveyed by FactSet. Adjusted earnings included a gain of 4 cents per share from the resolution of a U.S. tax audit.

Revenue for the period increased 12 percent from last year to $ 841 million. That figure, though, includes sales of games with online components, a revenue stream that the company and analysts prefer to spread out over time.

With that adjustment, Activision’s third-quarter revenue would have risen by 20 percent to $ 751 million — about $ 41 million above analysts’ projections.

The third quarter ended with a flourish as Activision sold 2.7 million copies of “World of Warcraft: Mists of Pandaria” in the first week after its Sept. 25 release.

CEO Bobby Kotick believes Activision has another hit on its hand with “Call of Duty: Black Ops II,” scheduled to go on sale Tuesday.

“We feel good about our product line-up, in spite of a difficult and challenging macroeconomic environment that could worsen,” Kotick said in an interview Wednesday.

Activision, based in Santa Monica, Calif., doesn’t expect the weak economy to keep people from buying its games as gifts during the upcoming holidays.

In the fourth quarter the company expects adjusted earnings of 70 cents per share on adjusted revenue of $ 2.41 billion. Analysts, on average, expect adjusted earnings of 67 cents per share on adjusted revenue of $ 2.34 billion.

Activision shares rose 23 cents, or 2 percent, to $ 11.36 in after-hours trading following the release of its earnings report.

Gaming News Headlines – Yahoo! News

Read More..

Rihanna unveils Chris Brown duet “Nobodies Business”

LOS ANGELES (Reuters) – R&B star Rihanna unveiled a duet entitled “Nobodies Business” with ex-boyfriend Chris Brown on Tuesday, three years after Brown was charged with assaulting her.

The song was part of an official track list that Barbadian singer Rihanna tweeted to her followers for her upcoming album “Unapologetic,” and comes after weeks of speculation in the media that the couple have rekindled their romance being spotted together at numerous events.

While Rihanna, 24, has stayed mum on her relationship status with Brown, the “Turn Up The Music” singer attended Rihanna‘s Halloween party last week and tweeted a photograph of himself dressed in Arab robes and a rifle.

Brown, 23, is currently halfway through his five-year probation after pleading guilty to assaulting Rihanna on the eve of the Grammy awards in 2009. He was ordered to complete community service and a domestic violence program.

Brown was given permission by a Los Angeles judge to embark on his European tour at a recent hearing overseeing his progress on his probation.

The former couple have had a tumultuous relationship in the last three years, including a restraining order against Brown following the assault.

But recently the two singers have made peace, coming together on a remix of Rihanna‘s raunchy song “Birthday Cake” earlier this year.

The Barbadian singer told Oprah Winfrey in an emotional interview in August that she and Brown now had a “very close friendship,” and that she still loved him.

Other collaborations on Rihanna‘s upcoming “Unapologetic” album include rapper Eminem, newcomer singer-songwriter Mikky Ekko and rapper Future.

(Reporting By Piya Sinha-Roy, editing by Jill Serjeant)

Celebrity News Headlines – Yahoo! News

Read More..

Novartis heart failure drug cuts death by 37 percent: study

LOS ANGELES (Reuters) – An experimental Novartis AG drug to treat hospitalized acute heart failure patients reduced deaths by 37 percent compared with a placebo and appeared to be safe, according to data from a late stage clinical trial presented on Tuesday.

The drug, serelaxin, which is a form of a human hormone that relaxes blood vessels and eases stress on the heart and other organs, is considered one of the most important medicines in the Swiss drugmaker’s developmental pipeline.

“With a meaningful mortality benefit, we believe Serelaxin could represent a $ 2.5 billion (annual) sales opportunity,” Deutsche Bank analysts said in a research note prior to release of the final data at the American Heart Association scientific meeting in Los Angeles.

Novartis said it now planned to seek approval for serelaxin. In the study of 1,161 patients, the drug cut deaths from any cause at six months by 37 percent and led to a marked reduction in worsening of heart failure during hospitalization, researchers said.

Patients who received 48 hours of continuously infused serelaxin experienced more than 45 percent fewer episodes of worsening heart failure symptoms than those who got a placebo.

Novartis had previously disclosed that serelaxin met one of the study’s two primary goals measuring relief of dyspnea, or extreme shortness of breath – a common symptom of acute heart failure – and that it reduced deaths. But the company did not say by how much. By one measure, serelaxin led to a 19 percent improvement in dyspnea, researchers said.

The drug failed to hit a secondary goal of the study that combined cardiovascular death with need for reshospitalizations, but researchers felt the life saving benefit was more important.

“We did have a startling death benefit. One of the reasons there may have been an inability to show a decrease in hospitalizations is more patients were alive to be rehospitalized,” said Dr John Teerlink, one of the trial’s co-lead researchers.

The data showed that only 29 acute heart failure patients would have to be treated with serelaxin to prevent one cardiovascular death, said Teerlink, a cardiologist and heart failure specialist at the San Francisco VA Medical Center.

Doctors say there is an enormous need for a treatment for acute heart failure, with few available options for the condition in which the heart is unable to pump enough blood.

“If it was approved we would not only use it, there would be a mandate to use it because we don’t have anything for acute decompensated heart failure,” said Dr. Milton Packer, a prominent cardiologist from the University of Texas Southwest Medical Center in Dallas, who was not involved in the study.

“If that mortality finding is real, boy are we going to get excited,” said Packer, who has been a member of FDA advisory panels for heart drugs.

There are more than one million hospitalizations in the United States each year for acute heart failure and another million in Europe. About half of all patients die within five years of diagnosis, often as a result of acute episodes that require urgent hospital care.

TREATMENT BENEFITS

The study showed the Novartis drug also reduced the duration of time spent in intensive care units by almost half a day and cut the length of hospital stay by almost a full day.

There was no difference in serious side effects between the two groups, but there was a significant increase in kidney impairment in the placebo group, as the Novartis drug appears to prevent worsening of kidney function, researchers said.

Despite missing some of the pre-set end points, or goals, of the study, Novartis said it is likely to seek approval of the drug based on the trial results.

“We believe this is a strong set of data and have started discussions with the main regulatory agencies. Our filing strategy will be determined by the outcome of these discussions,” said Ameet Nathwani, Novartis’ global business franchise head for critical care.

Dr John McMurry of the University of Glasgow, who was on a panel to critique the study, said that if there were a second serelaxin trial that also showed a mortality benefit it would be hard for health regulators to ignore.

“I think the agent was beneficial. This drug is doing something good in terms of relief,” he said.

(Reporting by Bill Berkrot and Deena Beasley. Editing by Andre Grenon and Richard Pullin)

Medications/Drugs News Headlines – Yahoo! News

Read More..

Novartis heart failure drug cuts death by 37 percent: study

LOS ANGELES (Reuters) – An experimental Novartis AG drug to treat hospitalized acute heart failure patients reduced deaths by 37 percent compared with a placebo and appeared to be safe, according to data from a late stage clinical trial presented on Tuesday.

The drug, serelaxin, which is a form of a human hormone that relaxes blood vessels and eases stress on the heart and other organs, is considered one of the most important medicines in the Swiss drugmaker’s developmental pipeline.

“With a meaningful mortality benefit, we believe Serelaxin could represent a $ 2.5 billion (annual) sales opportunity,” Deutsche Bank analysts said in a research note prior to release of the final data at the American Heart Association scientific meeting in Los Angeles.

Novartis said it now planned to seek approval for serelaxin. In the study of 1,161 patients, the drug cut deaths from any cause at six months by 37 percent and led to a marked reduction in worsening of heart failure during hospitalization, researchers said.

Patients who received 48 hours of continuously infused serelaxin experienced more than 45 percent fewer episodes of worsening heart failure symptoms than those who got a placebo.

Novartis had previously disclosed that serelaxin met one of the study’s two primary goals measuring relief of dyspnea, or extreme shortness of breath – a common symptom of acute heart failure – and that it reduced deaths. But the company did not say by how much. By one measure, serelaxin led to a 19 percent improvement in dyspnea, researchers said.

The drug failed to hit a secondary goal of the study that combined cardiovascular death with need for reshospitalizations, but researchers felt the life saving benefit was more important.

“We did have a startling death benefit. One of the reasons there may have been an inability to show a decrease in hospitalizations is more patients were alive to be rehospitalized,” said Dr John Teerlink, one of the trial’s co-lead researchers.

The data showed that only 29 acute heart failure patients would have to be treated with serelaxin to prevent one cardiovascular death, said Teerlink, a cardiologist and heart failure specialist at the San Francisco VA Medical Center.

Doctors say there is an enormous need for a treatment for acute heart failure, with few available options for the condition in which the heart is unable to pump enough blood.

“If it was approved we would not only use it, there would be a mandate to use it because we don’t have anything for acute decompensated heart failure,” said Dr. Milton Packer, a prominent cardiologist from the University of Texas Southwest Medical Center in Dallas, who was not involved in the study.

“If that mortality finding is real, boy are we going to get excited,” said Packer, who has been a member of FDA advisory panels for heart drugs.

There are more than one million hospitalizations in the United States each year for acute heart failure and another million in Europe. About half of all patients die within five years of diagnosis, often as a result of acute episodes that require urgent hospital care.

TREATMENT BENEFITS

The study showed the Novartis drug also reduced the duration of time spent in intensive care units by almost half a day and cut the length of hospital stay by almost a full day.

There was no difference in serious side effects between the two groups, but there was a significant increase in kidney impairment in the placebo group, as the Novartis drug appears to prevent worsening of kidney function, researchers said.

Despite missing some of the pre-set end points, or goals, of the study, Novartis said it is likely to seek approval of the drug based on the trial results.

“We believe this is a strong set of data and have started discussions with the main regulatory agencies. Our filing strategy will be determined by the outcome of these discussions,” said Ameet Nathwani, Novartis’ global business franchise head for critical care.

Dr John McMurry of the University of Glasgow, who was on a panel to critique the study, said that if there were a second serelaxin trial that also showed a mortality benefit it would be hard for health regulators to ignore.

“I think the agent was beneficial. This drug is doing something good in terms of relief,” he said.

(Reporting by Bill Berkrot and Deena Beasley. Editing by Andre Grenon and Richard Pullin)

Medications/Drugs News Headlines – Yahoo! News

Read More..

Voting Goes From Inalienable Right to Bragging Right

A woman I went to high school with voted for Barack Obama today. I know this because she posted a picture of her ballot to Facebook (FB). She quickly deleted it—perhaps because, according to the Citizen Media Law Project, doing so in Illinois, where she lives, is actually illegal—but not before five other people took self-portraits of themselves wearing their “I voted!” stickers. Media outlets are in on the game, too; the New York Times is soliciting readers’ stylized Instagram photos while NPR wants to know what’s on people’s election-night playlist.

Do people make election-night playlists? Then how do they listen to Wolf Blitzer? This year, voting in America has moved from an inalienable right to a bragging right. It’s the democratic equivalent of telling everyone how well you’re sticking to your diet.

Social media has changed since the 2008 election, when Sarah Palin impersonations abounded on YouTube (GOOG) but the Internet had not yet become infatuated with sepia-toning its every move. There were 10.3 million tweets about the Denver presidential debate last month—of which, I admit, I contributed at least a dozen. That’s one tweet for every 14 people who reportedly watched it. Today, Facebook is tracking the number of people who clicked on its “I voted” prompt in real time. But how useful are these statistics? The site currently shows that only 8 percent of its self-identified voters are over age 55, while in 2008 that age group had a voter turnout of roughly 70 percent. And for some reason, nearly twice as many women have voted on Facebook as men. Maybe that’s because Lena Dunham has asked them to tweet pictures of the outfits they’re wearing to the polls.

In a way, this is an unofficial grassroots version of Rock the Vote, the nonpartisan organization that tried to get young people to the polls by making the democratic process seem cool. But can you actually guilt-trip someone into voting with a Thomas Jefferson quote translated into LOL-speak and a picture of a sticker? Or change someone’s mind with a grammatically incorrect, all-caps rant about a candidate? Who are these pictures for, anyway?

I can’t wait until next week, when we’ll go back to posting pictures of our lunch.

Businessweek.com — Top News

Read More..

Officials: New mass graves found in Ivory Coast

ABIDJAN, Ivory Coast (AP) — Up to 10 new mass graves have been discovered near the site of a July attack on a camp for displaced people, officials said Tuesday, amid allegations that initial casualty totals were downplayed to mask killings carried out by the national army.

Rights groups claim summary executions were carried out by the Republican Forces of Ivory Coast, known by its French acronym of FRCI. Last month, officials found six bodies in a well close to the former campsite in the western town of Duekoue.

Government, army and U.N. officials toured 10 more graves in the same area on Saturday, said Paul Mondouho, vice-mayor of Duekoue. He said the graves had first been identified by civilians, and that officials did not know the number of bodies they contained because they had not yet been properly exhumed.

“People were suspecting the presence of bodies in these graves because of the smell coming out of them and because of the shoes we saw nearby,” Mondouho said.

Prosecutor Noel Dje Enrike Yahau, who is based in the commercial capital of Abidjan, confirmed that multiple new graves had been discovered but could not provide details. U.N. officials and the local prosecutor in charge of investigating the suspected killings could not be reached Tuesday.

U.N. spokeswoman Sylvie van den Wildenberg confirmed that U.N. forces helped Ivorian authorities secure a perimeter around 10 wells “similar to the one in which six bodies were found,” and that “some of those wells are suspected mass graves.”

She stressed that Ivorian authorities were leading the investigation but that the U.N. was able to provide assistance.

Army spokesmen could not be reached Tuesday. The Justice Ministry has previously vowed to investigate the discovery of the initial grave.

On the morning of July 20, a mob descended on the U.N.-guarded Nahibly camp, which housed 4,500 people displaced by violence in Ivory Coast, burning most of the camp to the ground. Officials said at the time that six people were killed.

The attack was prompted by the shooting deaths of four men and one woman on the night of July 19, according to local officials and residents. In response a mob of some 300 people overran the camp on the morning of July 20 after the perpetrators of the shootings reportedly fled there.

The victims in the July 19 attack lived in a district dominated by the Malinke ethnic group, which largely supported President Alassane Ouattara in the disputed November 2010 election. The camp primarily housed members of the Guere ethnic group, which largely supported former President Laurent Gbagbo.

Gbagbo’s refusal to cede office despite losing the election to Ouattara sparked months of violence that claimed at least 3,000 lives.

Albert Koenders, the top U.N. envoy to Ivory Coast, said one week after the attack that U.N. security forces had been inside and outside the camp at the time but that no Ivorian security forces were present. He said the U.N. forces decided not to fire at a large group of people that were attacking the camp in order to avoid “a massacre.”

Several witnesses have said soldiers and traditional hunters, known as dozos, participated in the attack on the camp. Both military and dozo leaders have denied the claims, saying they had tried to protect the camp.

In a statement released Friday, the International Federation for Human Rights, known by its French acronym of FIDH, said it had information — including the preliminary results of autopsies — confirming that the six bodies found in October were men who had been summarily executed by the army.

“The disappearance of dozens of displaced persons after the attack, as well as confirmation of cases of summary and extra-judicial executions, suggest a much higher victim rate than the official figures report,” said the organization, which counts Ivorian civil society groups among its members.

Duekoue was one of the hardest-hit towns during the post-election violence. The U.N. has established that at least 505 people were killed in and around the town, including during a notorious March 2011 massacre that claimed hundreds of lives and was allegedly carried out by fighters loyal to Ouattara.

Duekoue residents belonging to ethnic groups that supported Gbagbo have long complained about abuses carried out by the FRCI, with some pointing to the direct involvement of the local commander, Kone Daouda. FIDH said in its statement that Daouda had been transferred following the discovery of the grave in October, and called for him to be interrogated over the matter.

The group also said two FRCI members were being “actively sought” after failing to return to their barracks on Oct. 16, noting that they are believed to have fled to neighboring Burkina Faso.

Africa News Headlines – Yahoo! News

Read More..

HANNITY ON TWEET

“I learned a big civics lesson today.” — Fox News Channel host Sean Hannity, who tweeted a picture of his filled-out ballot (for Mitt Romney, natch), only to learn that appeared to break the law in New York state.

— David Bauder — http://twitter.com/dbauder

___

EDITOR’S NOTE — Election Watch shows you Election Day 2012 through the eyes of Associated Press journalists. Follow them on Twitter where available with the handles listed after each item.

Social Media News Headlines – Yahoo! News

Read More..

Rare John Lennon letter to Eric Clapton up for auction

LOS ANGELES (Reuters) – John Lennon held out the promise he could bring out more musical greatness in legendary guitarist Eric Clapton in a letter that could fetch as much as $ 30,000 when it is sold at auction next month, the organizers of the sale said on Monday.

The signed, hand-written letter by the Beatle, who died in 1980 at the age of 40, is one of a selection from some of the world’s great musicians that will go under the hammer in Los Angeles at the Profiles in History auction on December 18.

In a draft letter dated September 29, 1971, Lennon expressed his respect and admiration for British guitarist Clapton and suggested that they form a band together.

“Eric, I know I can bring out something great, in fact greater in you that had been so far evident in your music. I hope to bring out the same kind of greatness in all of us, which I know will happen if/when we get together,” Lennon wrote in the letter.

The letter will hold special significance for Beatles fans as auctioneer Joe Maddalena said it was widely known that there were problems in the Fab Four’s relationships with each other, and that Clapton had almost become a Beatle.

Clapton played in the Plastic Ono Band, formed by Lennon and Yoko Ono in 1969 before the breakup of the Beatles in 1970. He also played on the George Harrison song “While My Guitar Gently Weeps”, which was on the Beatles’ White Album.

“There was a point in time when George Harrison thought about leaving the band and his replacement was Clapton, so this letter is a link of what could have been,” Maddalena said.

The letter is one of 300 manuscripts and letters from literary, musical and political greats, that will be auctioned from the holdings of an American collector.

“What we know of history is from the written word, without these letters, it would all be verbal. It’s a really unique area of collecting as you’re getting a glimpse into people’s minds,” Maddalena said.

Other highlights include a handwritten letter from George Washington, with a pre-sale estimate of up to $ 300,000, and a Charles Dickens manuscript with an obituary of novelist William Thackeray, expected to fetch between $ 40,000 and $ 60,000.

Also on the auction block is a signed, handwritten letter from German composer Ludwig van Beethoven to Tobias Haslinger, a friend of his publisher, in which the musician discussed the second performance of his Ninth Symphony and the Missa Solemnis, two of his most revered works.

The letter, written in German, is undated, but both the Ninth Symphony and Missa Solemnis debuted in performances in 1824. Because of the rarity of the letter, it is estimated it will sell for between $ 40,000 and $ 60,000.

Other items going under the hammer include a signed letter in Russian by composer Peter Ilyich Tchaikovsky, which has a pre-sale estimate of $ 10,000 to $ 15,000, and a letter by composer George Gershwin dated March 24, 1932, in which he compares his compositions “Rhapsody in Blue” and “An American in Paris”.

The Gershwin letter is expected to sell for as much as $ 3,000, according to the auction house.

(Reporting By Piya Sinha-Roy; editing by Patricia Reaney; and Peter Galloway)

Music News Headlines – Yahoo! News

Read More..

Appeals court questions Arizona’s late-term abortion ban

SAN FRANCISCO (Reuters) – A federal appeals court panel on Monday sharply questioned lawyers defending an Arizona law that bans late-term abortions starting at 20 weeks of pregnancy except in medical emergencies, which opponents say is the toughest in the United States.

In San Francisco, a three-judge panel of the 9th U.S. Circuit Court of Appeals heard the case after it blocked the Republican-backed Arizona law from going into effect earlier this year. Three abortion providers challenged the law in court.

The Arizona law bars doctors from performing abortions starting at 20 weeks of pregnancy, except in medical emergencies, and could send doctors who perform them to jail.

The American Civil Liberties Union, which is suing to stop the law, said it was more extreme than similar laws elsewhere, because the way Arizona measures gestation means it would bar abortions two weeks earlier than in other states.

Those states also set the limit at 20 weeks but have different ways to calculate gestation time. Arizona already bans abortions at the point of viability, when a fetus might survive outside the womb, generally at 23 to 24 weeks.

Judge Andrew Kleinfeld, a panel member appointed by former President George H.W. Bush, repeatedly expressed concern that the law might not afford women the opportunity to abort a fetus with birth defects in cases where the defects are not apparent until just before 20 weeks.

He also questioned the need to prohibit abortions at that stage of the pregnancy, especially for fetuses bound to develop “horrible birth defects.”

“They’re basically born into hell and then die,” Kleinfeld said. “I don’t see how the courts could act before viability” of the fetus.

“With due respect, that’s the woman’s problem,” responded David Cole, Arizona’s solicitor general. “She should have made that decision earlier.”

William Montgomery, the attorney for Maricopa County in Arizona who also defended the law before the appeals panel, said new medical evidence showed a fetus has the capacity to feel pain during an abortion at 20 weeks of development.

But Judge Marsha Siegel Berzon called that a “red herring” in terms of the constitutional questions the law raises.

The three-judge panel did not say when it could make a final ruling in the case. The U.S. Supreme Court legalized abortion nationwide in 1973, but has allowed states to place restrictions on the procedure from the time of viability unless the woman’s health was at risk.

In July, days before the 9th Circuit panel blocked the law until it could fully consider the case, U.S. District Judge James Teilborg ruled that the Arizona measure was consistent with limits federal courts have allowed.

Talcott Camp, deputy director of the ACLU reproductive freedom project, said the Arizona law’s exception to allow late-term abortion applies only in immediate emergencies if delay can jeopardize a woman’s life or seriously harm her health.

“The medical emergency exception is truly, horrifically narrow,” she said in a phone interview. “This is a law that allows her to get an abortion only when she is in emergency crisis.”

Aside from Arizona, seven U.S. states have put laws into effect in the past two years banning late-term abortions, based on hotly debated medical research suggesting a fetus feels pain starting at 20 weeks of gestation, according to the ACLU.

(Editing by Alex Dobuzinskis and Cynthia Johnston. Desking by Christopher Wilson)

Health News Headlines – Yahoo! News

Read More..

Appeals court questions Arizona’s late-term abortion ban

SAN FRANCISCO (Reuters) – A federal appeals court panel on Monday sharply questioned lawyers defending an Arizona law that bans late-term abortions starting at 20 weeks of pregnancy except in medical emergencies, which opponents say is the toughest in the United States.

In San Francisco, a three-judge panel of the 9th U.S. Circuit Court of Appeals heard the case after it blocked the Republican-backed Arizona law from going into effect earlier this year. Three abortion providers challenged the law in court.

The Arizona law bars doctors from performing abortions starting at 20 weeks of pregnancy, except in medical emergencies, and could send doctors who perform them to jail.

The American Civil Liberties Union, which is suing to stop the law, said it was more extreme than similar laws elsewhere, because the way Arizona measures gestation means it would bar abortions two weeks earlier than in other states.

Those states also set the limit at 20 weeks but have different ways to calculate gestation time. Arizona already bans abortions at the point of viability, when a fetus might survive outside the womb, generally at 23 to 24 weeks.

Judge Andrew Kleinfeld, a panel member appointed by former President George H.W. Bush, repeatedly expressed concern that the law might not afford women the opportunity to abort a fetus with birth defects in cases where the defects are not apparent until just before 20 weeks.

He also questioned the need to prohibit abortions at that stage of the pregnancy, especially for fetuses bound to develop “horrible birth defects.”

“They’re basically born into hell and then die,” Kleinfeld said. “I don’t see how the courts could act before viability” of the fetus.

“With due respect, that’s the woman’s problem,” responded David Cole, Arizona’s solicitor general. “She should have made that decision earlier.”

William Montgomery, the attorney for Maricopa County in Arizona who also defended the law before the appeals panel, said new medical evidence showed a fetus has the capacity to feel pain during an abortion at 20 weeks of development.

But Judge Marsha Siegel Berzon called that a “red herring” in terms of the constitutional questions the law raises.

The three-judge panel did not say when it could make a final ruling in the case. The U.S. Supreme Court legalized abortion nationwide in 1973, but has allowed states to place restrictions on the procedure from the time of viability unless the woman’s health was at risk.

In July, days before the 9th Circuit panel blocked the law until it could fully consider the case, U.S. District Judge James Teilborg ruled that the Arizona measure was consistent with limits federal courts have allowed.

Talcott Camp, deputy director of the ACLU reproductive freedom project, said the Arizona law’s exception to allow late-term abortion applies only in immediate emergencies if delay can jeopardize a woman’s life or seriously harm her health.

“The medical emergency exception is truly, horrifically narrow,” she said in a phone interview. “This is a law that allows her to get an abortion only when she is in emergency crisis.”

Aside from Arizona, seven U.S. states have put laws into effect in the past two years banning late-term abortions, based on hotly debated medical research suggesting a fetus feels pain starting at 20 weeks of gestation, according to the ACLU.

(Editing by Alex Dobuzinskis and Cynthia Johnston. Desking by Christopher Wilson)

Health News Headlines – Yahoo! News

Read More..